MDHOET:
556
Braun, U; Shulgin, AT; Braun, G. Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine). J. Pharm. Sci., 1 Jan 1980, 69 (2), 192–195. 513 kB. https://doi.org/10.1002/jps.2600690220 #IIm
Braun, U; Shulgin, AT; Braun, G. Prüfung auf zentrale Aktivität und Analgesia von N-substituierten Analogen des Amphetamin-Derivates 3,4-Methylendioxyphenylisopropylamin. Arzneim. Forsch., 1 Jan 1980, 30 (5), 825–830. 1.5 MB. #IIO
Koper, C; Ali-Tolppa, E; Bozenko, JS; Dufey, V; Puetz, M; Weyermann, C; Zrcek, F. Identification of a new amphetamine type stimulant: 3,4-Methylenedioxy-(2-hydroxyethyl)amphetamine (MDHOET). Microgram J., 1 Jul 2005, 3 (3–4), 166–174. 406 kB. MS,NMR,IR
King, LA. New phenethylamines in Europe. Drug Test. Anal., 1 Jul 2014, 6 (7-8), 808-818. 472 kB. https://doi.org/10.1002/dta.1570
Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.
EMCDDA. New drugs in Europe, 2005, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2006. 1.2 MB. #MDHOET
N-Me-MMDA-2 · METHYL-MMDA-2
FM · Hemi-flyscaline · M-hemiFLY · MeO-2C-ISF
N-iPr-DHA-βk · Phenisonone
N,2-Dimethoxymethcathinone · DOMC